Prognostic nomogram for multiple myeloma early relapse after autologous stem cell transplant in the novel agent era.

The present nomogram could serve as a feasible and accurate prediction of ER in novel drug induction transplantation-eligible MM patients, which could help modify the post-ASCT strategy for patients at high risk of ER.